Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.50 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.50 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.50 |
| ▸ | F2 | P00734 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.46 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29117097 | 0.90 | CA12 (0.45) | ALDH1A1LMNAADRB2ADRB1ADRB3 | |
| SCHEMBL2729575 | 0.86 | TSHR (0.54) | ALDH1A1TSHRLMNAADRB2ADRB1 | |
| SCHEMBL28013511 | 0.85 | TSHR (0.58) | ALDH1A1TSHRLMNAADRB2ADRB1 | |
| SCHEMBL1162598 | 0.83 | ALDH1A1 (0.57) | ALDH1A1TSHRLMNAADRB2ADRB1 | |
| SCHEMBL670258 | 0.83 | ALDH1A1 (0.57) | ALDH1A1TSHRLMNAADRB2ADRB1 | |
| SCHEMBL582331 | 0.83 | ALDH1A1 (0.57) | ALDH1A1TSHRLMNAADRB2ADRB1 | |
| SCHEMBL420405 | 0.83 | ALDH1A1 (0.57) | ALDH1A1TSHRLMNAADRB2ADRB1 | |
| SCHEMBL13889265 | 0.82 | TSHR (0.50) | ALDH1A1TSHRLMNAADRB2ADRB1 | |
| SCHEMBL1532124 | 0.82 | TSHR (0.50) | ALDH1A1TSHRLMNAADRB2ADRB1 | |
| SCHEMBL31628410 | 0.82 | LMNA (0.65) | ALDH1A1TSHRLMNAADRB2ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102703331-A | Methods for screening biotransformation strain of resveratrol, identifying strain and biotransforming resveratrol by using strain | YONG CAO | 2012-10-03 | — | — | CN | claimed |
| EP-1886677-A1 | Use of an inducing agent for the treatment of blood, viral and cellular disorders | Perrine, Susan P. (US) | 2008-02-13 | — | — | EP | claimed |
| EP-1611885-A1 | Use of an inducing agent for the treatment of blood, viral and cellular disorders | Perrine, Susan P. (US) | 2006-01-04 | — | — | EP | claimed |
| US-5939456-A | METHOD OF STIMULATING THE EXPRESSION OF A GLOBIN PROTEIN, OR THE PROLIFERATION OR DEVELOPMENT OF ERYTHROID CELLS, MYELOID CELLS OR MEGAKARYOCYTIC CELLS FOR TREATING A DISORDER SELECTED FROM THE GROUP CONSISTING OF CYTOPENIA, AN ANEMIA AND | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 1999-08-17 | — | — | US | claimed |
| CN-1030608-A | PREPARATION OF BACTERIAL PROTEIN BY SOLID FERMENTATION OF MIXED INOCULATED CRUDE STARCH MATERIAL AND METHOD FOR STRAIN BREEDING THEREOF | GUANGDONG INST MICROBIOLOGY (CN) | 1989-01-25 | — | — | CN | claimed |
| US-20230372311-A1 | COMPOSITIONS AND METHODS OF TREATING AGE-RELATED RETINAL DYSFUNCTION | UNIV CALIFORNIA (US) | 2023-11-23 | — | — | US | disclosed |
| US-20230346788-A1 | METHODS FOR TREATING VIRAL DISORDERS | TRUSTEES OF BOSTON UNIVERSITY (US) | 2023-11-02 | — | — | US | disclosed |
| US-11701363-B2 | Methods for treating viral disorders | TRUSTEES OF BOSTON UNIVERSITY (US) | 2023-07-18 | — | — | US | disclosed |
| WO-2023108080-A1 | BACILLUS COAGULANS STRAIN, COMPOSITIONS THEREOF, AND METHODS OF USE | DEERLAND PROBIOTICS & ENZYMES, INC. (US) | 2023-06-15 | — | — | WO | disclosed |
| US-20230149413-A1 | HISTONE DEACETYLASE INHIBITORS FOR USE IN IMMUNOTHERAPY | Viracta Subsidiary, Inc. | 2023-05-18 | — | — | US | disclosed |
| US-11649377-B2 | Polishing liquid, polishing liquid set and polishing method | RESONAC CORPORATION (JP) | 2023-05-16 | — | — | US | disclosed |
| CN-110708956-B | Microcapsules comprising cycloheptanether and polyurea derived from diphenylmethane diisocyanate or an oligomer thereof in the core | 巴斯夫农业公司 | 2022-10-04 | — | — | CN | disclosed |
| US-6197743-B1 | CONCURRENT ADMINISTERING INDUCTION AGENT AND VIRICIDES | THE TRUSTEES OF BOSTON UNIVERSITY | 2001-03-06 | — | — | US | disclosed |
| EP-0969869-A2 | COMPOSITIONS COMPRISING AN INDUCING AGENT AND AN ANTI-VIRAL AGENT FOR THE TREATMENT OF BLOOD, VIRAL AND CELLULAR DISORDERS | Perrine, Susan P. (US) | 2000-01-12 | — | — | EP | disclosed |
| WO-1999040883-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS | FALLER DOUGLAS V (US) | 1999-08-19 | — | — | WO | disclosed |
| US-5939456-A | METHOD OF STIMULATING THE EXPRESSION OF A GLOBIN PROTEIN, OR THE PROLIFERATION OR DEVELOPMENT OF ERYTHROID CELLS, MYELOID CELLS OR MEGAKARYOCYTIC CELLS FOR TREATING A DISORDER SELECTED FROM THE GROUP CONSISTING OF CYTOPENIA, AN ANEMIA AND | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 1999-08-17 | — | — | US | disclosed |
| WO-1998004290-A2 | COMPOSITIONS COMPRISING AN INDUCING AGENT AND AN ANTI-VIRAL AGENT FOR THE TREATMENT OF BLOOD, VIRAL AND CELLULAR DISORDERS | PERRINE SUSAN P (US) | 1998-02-05 | — | — | WO | disclosed |
| CN-1030608-A | PREPARATION OF BACTERIAL PROTEIN BY SOLID FERMENTATION OF MIXED INOCULATED CRUDE STARCH MATERIAL AND METHOD FOR STRAIN BREEDING THEREOF | GUANGDONG INST MICROBIOLOGY (CN) | 1989-01-25 | — | — | CN | disclosed |
| US-4500713-A | TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACID DERIVATIVE AS ANTIHYPERTENSIVE AGENT | USV PHARMACEUTICAL CORPORATION (US) | 1985-02-19 | — | — | US | disclosed |
| US-4080209-A | Photographic light-sensitive material | FUJI PHOTO FILM CO., LTD. (JA) | 1978-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230372311-A1 | COMPOSITIONS AND METHODS OF TREATING AGE-RELATED RETINAL DYSFUNCTION | RBP4, ALDH1A2, RBP1 | ALDH1A1 1751/4885TSHR 2820/4885LMNA 147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.